Anthony P. Bihl III - May 23, 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: Interim CEO, Director
Signature: /s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol: BVS
Transactions as of: May 23, 2023
Transactions value $: $290,988
Form type: 4
Date filed: 5/24/2023, 09:17 PM
Previous filing: Apr 12, 2023
Next filing: Jun 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Purchase	$291K	+125K		$2.33	125K	May 23, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.25 to $2.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.25 to $2.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.